DE:25I Stock Latest News
Company AnnouncementsImmuPharma Advances Global Patent Strategy for P140 Autoimmune Precision Therapy1M ago
Company AnnouncementsImmuPharma’s P140 Shows Promise in Preclinical MASH Study1M ago
Company AnnouncementsImmuPharma narrows operating loss as fundraising funds P140 and Kapiglucagon push1M ago
Company AnnouncementsImmuPharma taps Kymos as bioanalytical partner to advance Kapiglucagon diabetes programme2M ago
Company AnnouncementsImmuPharma Taps Thermo Fisher as CDMO for Kapiglucagon Diabetes Program3M ago
Company AnnouncementsImmuPharma shareholders back all resolutions at 2026 AGM4M agoCompany AnnouncementsImmuPharma taps Bachem to manufacture Kapiglucagon API for Type 1 diabetes program4M ago
Company AnnouncementsImmuPharma flags early-stage P140 glioblastoma research while reaffirming autoimmune focus4M ago
Company AnnouncementsImmuPharma flags Incanthera board shake-up as chairman steps down5M ago- Company AnnouncementsImmuPharma Sets June AGM as 2025 Annual Report Reaches Shareholders5M ago
Company AnnouncementsImmuPharma Narrows Loss, Raises Funds as P140 Autoimmune Platform Advances5M ago
Company AnnouncementsImmuPharma Advances Kapiglucagon Diabetes Program With IND-Enabling Plan6M ago
Company AnnouncementsImmuPharma Secures Shareholder Backing and Funding to Drive P140 and Kapiglucagon Programs6M agoCompany AnnouncementsImmuPharma Advances P140 Patent and Data as It Targets 2026 Licensing Deal7M ago
Company AnnouncementsImmuPharma Raises £6.47m as Retail Offer Completes Ahead of AIM Share Admission7M ago
Company AnnouncementsImmuPharma Calls General Meeting to Approve Fundraising Plans7M ago
Company AnnouncementsImmuPharma Sets Investor Presentation on Pipeline and £7.5m Fundraise7M ago- Company AnnouncementsImmuPharma Launches £1.5m WRAP Retail Share Offer Alongside £7.5m Subscription7M ago
Company AnnouncementsImmuPharma raises up to £7.5m to fast‑track Kapiglucagon as P140 licensing talks advance7M agoCompany AnnouncementsImmuPharma Targets Investor Visibility at JP Morgan Conference and Biotech Showcase10M ago
Company AnnouncementsImmuPharma Extends P140 Partnership Timeline Amid Strong Financial Position11M ago